Is IBI362 the same as mazdutide?

Yes. IBI362 and LY3305677 are development codes listed as aliases on this site's mazdutide profile. They name the same GLP-1 and glucagon receptor dual agonist, molecular weight about 4,800 daltons, approved in China in 2025 for obesity and type 2 diabetes and not FDA approved. The codes are laboratory labels, not a second drug and not a US approval. Full record at /compounds/mazdutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.